Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: RAD001|DRUG: Gemcitabine|DRUG: Cisplatin
Sponsor: National Cancer Center, Korea